FDA approvaloutcome: successconf 1.00
khindivi — FDA approval
$ETON · Eton Pharmaceuticals, Inc.
Event date
May 28, 2025
374 days ago
Sponsor runway
cash-flow +
$19.7M liquid
Evidence
Comparable historical fda approvals· last 5 years · same event type
100% hit rate (10/10)
| Ticker | Drug | Date | Outcome |
|---|---|---|---|
| $INCY | zynyz | 2026-05-18 | success |
| $INCY | jakafi xr | 2026-05-01 | success |
| $AXSM | auvelity | 2026-04-30 | success |
| $INCY | zynyz | 2026-03-30 | success |
| $BIIB | spinraza | 2026-03-27 | success |
| $CORT | lifyorli | 2026-03-25 | success |
| $RYTM | imcivree | 2026-03-19 | success |
| $ASND | yuviwel | 2026-02-27 | success |
| $BMRN | palynziq | 2026-02-27 | success |
| $ETON | desmoda | 2026-02-25 | success |
Recent insider activity· ±90 days
4 insiders · 2 buys · 10 sells
Sell
2025-08-20Gruber James R.
Chief Financial Officer
2,631 @ $16.02$42K
Sell
2025-08-19Gruber James R.
Chief Financial Officer
39,082 @ $16.16$632K
Sell
2025-06-16Krempa David
Chief Business Officer
10,223 @ $14.73$151K
Sell
2025-06-13Krempa David
Chief Business Officer
6,800 @ $14.77$100K
Sell
2025-06-12Krempa David
Chief Business Officer
16,977 @ $14.92$253K
Buy
2025-06-10Opaleye Management Inc.
10%+ Owner
2,930 @ $15.82$46K
Buy
2025-06-10Opaleye Management Inc.
10%+ Owner
5,000 @ $15.82$79K
Sell
2025-06-05BRYNJELSEN SEAN
President & CEO
70,000 @ $16.81$1.18M
Sell
2025-06-04BRYNJELSEN SEAN
President & CEO
70,000 @ $17.00$1.19M
Sell
2025-06-03BRYNJELSEN SEAN
President & CEO
8,655 @ $18.38$159K
Sell
2025-06-03BRYNJELSEN SEAN
President & CEO
60,945 @ $17.38$1.06M
Sell
2025-06-03BRYNJELSEN SEAN
President & CEO
400 @ $19.02$8K